New chin filler faces off against competitor in Head-to-Head trial
NCT ID NCT05986630
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study compares a new injectable filler, TEOSYAL® TPVM, to an existing one for improving chin shape and lower face aging. About 155 healthy adults with moderate to severe chin retrusion will receive treatment. The goal is to see if the new filler is as safe and effective as the current option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Care- Geneva
Geneva, Switzerland
Conditions
Explore the condition pages connected to this study.